What are Viral Vectors and Plasmid DNA used for?

Viral vectors and plasmid DNA are utilized in gene therapy, gene editing, and vaccine development to deliver genetic material into cells for therapeutic or research purposes.

How big is the Viral Vectors and Plasmid DNA Manufacturing Market?

The global Viral Vectors and Plasmid DNA Manufacturing Market size was estimated at USD 5.3 Billion in 2023 and is expected to reach USD 36.5 Billion in 2033.

Who are the key companies/players in the Viral Vectors and Plasmid DNA Manufacturing Market?

Some of the key players in the Viral Vectors and Plasmid DNA Manufacturing Markets are Merck KGaA, Lonza, FUJIFILM Diosynth Biotechnologies, Thermo Fisher Scientific, Cobra Biologics, Catalent Inc., Wuxi Biologics, Takara Bio Inc., Waisman Biomanufacturing, Genezen laboratories, Batavia Biosciences, Miltenyi Biotec GmbH.

How do Viral Vectors and Plasmid DNA contribute to medical advancements?

These manufacturing technologies enable the development of innovative treatments for various diseases, including genetic disorders, cancers, and infectious diseases, leading to improved patient outcomes.

What factors are driving the growth of the Viral Vectors and Plasmid DNA Manufacturing Market?

The increasing demand for gene therapy, advancements in gene editing technologies, rising research activities, investments in the pharmaceutical and biotechnology industries, favorable regulatory conditions, and integration of advanced computing technologies are driving market growth.

How do Viral Vectors and Plasmid DNA manufacturing technologies impact healthcare?

These technologies enable the development of targeted therapies, personalized medicines, and novel vaccines, revolutionizing the treatment landscape and offering new hope for patients with challenging medical conditions.

Global Viral Vectors and Plasmid DNA Manufacturing Market By Vector Type (Adenovirus, Retrovirus, Adeno-Associated Virus (AAV), Lentivirus, Plasmids, Other Vector Types) By Workflow Upstream Manufacturing (Vector Amplification & Expansion, Vector Recovery/Harvesting) Downstream Manufacturing(Purification, Fill Finish) By Application (Antisense & RNAi Therapy, Gene Therapy, Cell Therapy, Vaccinology, Other Applications) By End-user (Pharmaceutical and Biopharmaceutical Companies, Research Institutes, Disease, Cancer, and Others) and by Region and Companies Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2024-2033

Published date: July 2024
Report ID: 13644
Number of Pages: 312
Format:

- Merck KGaA Company Profile
- Lonza Group AG Company Profile
- FUJIFILM Diosynth Biotechnologies
- Thermo Fisher Scientific Company Profile
- Cobra Biologics
- Catalent Inc.
- Wuxi Biologics
- Takara Bio Inc.
- Waisman Biomanufacturing
- Genezen laboratories
- Batavia Biosciences
- Miltenyi Biotec GmbH

Related Reports

Our Clients

Viral Vectors and Plasmid DNA Manufacturing Market

Report ID 13644
Published Date July 2024
Rating
- ★★★★★
  
  ★★★★★
- (53)

Buy Now

Trusted by more than 17382 organizations globally

✖

Request a Sample Report

We'll get back to you as quickly as possible